Culture

Story tips from Johns Hopkins experts on Covid-19

STUDY PROFILES IMMUNE CELLS FIGHTING COVID-19, MAY HELP GUIDE NEXT-GEN VACCINE DEVELOPMENT

Media Contact: Michael E. Newman, mnewma25@jhmi.edu

Even as the first vaccines for SARS-CoV-2, the virus that causes COVID-19, are being distributed, scientists and clinicians around the world have remained steadfast in their efforts to better understand how the human immune system responds to the virus and protects people against it. Now, a research team -- led by Johns Hopkins Medicine and in collaboration with ImmunoScape, a U.S.-Singapore biotechnology company -- has published one of the most comprehensive characterizations to date of a critical contributor to that protection: the response of immune system cells called T lymphocytes (more commonly known as T cells) in people who have recovered from SARS-CoV-2 infection.

The researchers, whose findings were posted online Jan. 11, 2021, in The Journal of Clinical Investigation, say that better defining which T cells interact with which specific portions of the SARS-CoV-2 virus -- as well as how those interactions can provide long-lasting immunity against COVID-19 -- may help spur development of the next generation of vaccines.

"We already knew that plasma from convalescent patients with COVID-19 -- those who have recovered from a SARS-CoV-2 infection -- can contain antibodies that neutralize the virus, which can then be used to help other patients with active infection," says study senior author Thomas Quinn, M.D., professor of medicine at the Johns Hopkins University School of Medicine and National Institutes of Health distinguished investigator at the National Institute of Allergy and Infectious Diseases. "Our study was designed to assess which T cells react to specific proteins of SARS-CoV-2, how they might complement neutralizing antibodies in recovery from infection and what can be done to optimize the process for long-term protection."

The T cells of interest to Quinn and his colleagues are known as CD8+ T cells, also called cytotoxic or killer T cells for their ability to eliminate foreign invaders such as bacteria and viruses from the body. To analyze them, the researchers collected blood samples from 30 convalescent patients who had recovered from mild cases of COVID-19. The six human leukocyte antigens (HLAs, as they are more commonly known, are cell-surface proteins that regulate the immune system and are part of each person's genetic profile) of the donors studied, Quinn says, are representative of some 73% of the continental U.S. population, meaning the study results have broad significance.

The samples were taken from 26 to 62 days after the donors stopped having COVID-19 symptoms, so that "their immune response would be fully matured in response to the virus and have primed certain CD8+ T cells against it," says Quinn. The Johns Hopkins Medicine researchers measured the level of neutralizing antibodies in the donors at various times post-recovery and stored samples for deeper analysis.

That assessment occurred when the donor samples were sent to ImmunoScape for the difficult task of identifying which T cells had responded to SARS-CoV-2. More specifically, the company's deep immune cell profiling method could show toward which virus proteins the T cells directed that response -- data that could provide valuable insight into the T cells' functional properties.

In a first-of-its-kind analysis, the ImmunoScape team used its highly sensitive HLA-SARS-CoV-2 tetramers -- laboratory-produced proteins that bind exclusively to their T cell targets -- to tag and identify the types of virus-recognizing CD8+ T cells. The samples were probed with 408 SARS-CoV-2 epitopes -- proteins that may elicit an immune response -- from the spikes on the virus surface, from the virus capsule and from nonstructural proteins inside the virus. The researchers then looked to see which T cells matched up with which epitopes.

"We found that 52 of the 408 epitopes were recognized by the T cells from the convalescent donors, with 18 of these epitope matchings previously unreported," says study co-author Aaron Tobian, M.D., Ph.D., director of the transfusion medicine division and professor of pathology at the Johns Hopkins University School of Medicine.
"Of these, 23% were derived from spike proteins -- the types targeted by the currently available COVID-19 vaccines -- while 14% were from capsule proteins and 63% were from nonstructural proteins that normally would not elicit an immune response."

Looking at the specific types of CD8+ T cells present at different times following recovery from COVID-19, the researchers found that as the levels of neutralizing antibodies increased in the convalescent plasma, so did the number of memory CD8+ T cells that recognized SARS-CoV-2 epitopes.

"That's good because those are the T cells you want to be primed in case you are exposed to SARS-CoV-2 a second time as they 'remember' the first infection and quickly direct the immune system to fight the virus before it takes root again," says Quinn.

Characterizing the CD8+ T cells in blood samples from convalescent patients that are specific to SARS-CoV-2 and, more importantly, specific to which viral epitopes, is an important achievement, Tobian adds.

"With this knowledge, we will be better equipped to design COVID-19 vaccines that produce a strong immune response and likely provide years of defense against SARS-CoV-2," he says.

Quinn and Tobian are available for interviews.

JOHNS HOPKINS MEDICINE RESEARCHER PART OF TEAM THAT QUANTIFIED 'PANDEMIC FATIGUE'

Media Contact: Danny Jacobs, djacob41@jhmi.edu

Anecdotal evidence of "pandemic fatigue" -- defined by the World Health Organization as "a lack of motivation to follow recommended COVID-19 protection behaviors" -- has been reported and shared almost as long as physical distancing guidelines have been around to fight the spread of the disease. Now, a research team, including a Johns Hopkins medical student, has the data to prove it.

The researchers analyzed almost nine months of survey responses to the University of Southern California's Understanding America Study, during which, twice each month, nearly 8,000 people across the United States were asked if they were practicing nonpharmaceutical interventions (NPIs), including physical distancing, frequent handwashing and wearing a mask.

The researchers used the data to develop a national NPI adherence index, detailed in a research letter published Jan. 22, 2021, in the Journal of the American Medical Association. The index, they report, started at 70 (out of 100, which would be total adherence) in early April 2020, dropped and plateaued in the high 50s in June, and increased slightly to 60 by Thanksgiving. The decrease was consistent across every region in the country.

"The plateau we see for overall NPI adherence in the results likely reflects some stability in the risk perception of different activities," says study lead author Matthew Crane, a second-year medical student at the Johns Hopkins University School of Medicine. "It's good to see adherence isn't continuing to drop at the initial rate because that would be terrible. But it's also disconcerting that protective behaviors overall have become relatively stable no matter what the national state of COVID-19 prevalence is. Given new, more transmissible variants of the virus that are arising globally, we really might need greater adherence to keep people safe."

The NPIs that had the largest decreases were remaining at home except for essential activities and exercise (79.6% of respondents did so in April 2020 compared with 41.1% by November), having no close contact with non-household members (63.5% decreased to 37.8%), not having visitors at their homes (80.3% decreased to 57.6%) and avoiding eating at restaurants (87.3% decreased to 65.8%).

"I was surprised [NPI adherence] wasn't more responsive to surges in COVID-19 cases," Crane says. "I thought it would fluctuate based on headlines and public health advisories."

The biggest increase was in mask wearing, which went from 39.2% to 88.6%. But Crane notes the survey asks if respondents have done or not done a specific action in the last seven days. That means a person might have worn a mask because it was required to visit a grocery store or another public space but was still opposed in principle to the rule.

"It might not be an endorsement of mask wearing," Crane says.

Crane hopes to continue to track NPI adherence and break down the survey data further, providing more insight for public health professionals to create targeted messaging to change behaviors.

"Until vaccines are very widely distributed, these protective behaviors will be the cornerstone of our national response. It's really what is going to get us through this, the NPIs," he says.

Crane is available for interviews.

MACHINE LEARNING TOOL GIVES EARLY WARNING OF CARDIAC ISSUES FOR PATIENTS WITH COVID-19

Media Contact: Danny Jacobs, djacob41@jhmi.edu

A team of Johns Hopkins University biomedical engineers and Johns Hopkins Medicine heart specialists have developed an algorithm that warns doctors several hours before patients hospitalized with COVID-19 experience cardiac arrest or blood clots.

The COVID-HEART predictor can forecast cardiac arrest for patients who have COVID-19 with a median early warning time of 18 hours, and it can predict blood clots three days in advance. It was developed with data from 2,178 patients treated at the five hospitals in the Johns Hopkins Health System between March 1 and Sept. 27, 2020.

"It's an early warning system to predict in real time these two outcomes in hospitalized COVID patients," said study senior author Natalia Trayanova, M.S., Ph.D., the Murray B. Sachs Professor of Biomedical Engineering and Medicine at the Johns Hopkins University School of Medicine. "The continuously updating predictor can help hospitals allocate the appropriate resources and proper interventions to attain the best outcomes for patients."

The paper was posted online Jan. 10, 2021, on the preprint website MedRxiv where scientists have been sharing urgent research related to COVID-19 throughout the pandemic. Trayanova's lab began the research in April 2020 with one of the first grants awarded from the National Science Foundation's Rapid Response Research effort.

Julie Shade, the study's lead author and a doctoral student in biomedical engineering at The Johns Hopkins University, built the machine-learning algorithm with more than 100 clinical data points, demographic information and laboratory results obtained from the JH-CROWN registry that Johns Hopkins established to collect COVID-19 data from every patient in the hospital system. Shade added other variables that she found reported by doctors on Twitter and from other preprint papers.

For example, the team did not anticipate that electrocardiogram (ECG) data would play a critical role in the prediction of blood clotting. But once it was added, the ECG data became one of the most accurate indicators for the condition, Trayanova said.

The researchers' next step is to develop the best method for setting up the technology in hospitals to aid in the care of patients with COVID-19.

Trayanova is available for interviews.

STUDY SHOWS PANDEMIC STRESS AFFECTS HOW PARENTS FEED THEIR CHILDREN

Media Contact: Waun'Shae Blount, wblount1@jhmi.edu

The COVID-19 pandemic has dramatically affected the lives of families everywhere. Household routines have changed, with families forced to spend more time than usual at home. School-aged children may have to prepare their own snacks and meals in between virtual classes, and parents might have less time to cook family meals because of their work-from-home schedules. Also, some parents have lost income, reducing family food budgets and changing the ability to afford healthy foods.

Johns Hopkins Medicine researchers surveyed families across the United States to learn how stress related to the pandemic is affecting the ways parents feed their children and in turn, what the children are eating.

A report on the findings was posted online as part of the journal Appetite's January 2021 special issue about COVID-19 impacts on food intake, appetite and weight status.

"Providing healthy meals and snacks to our kids can be a challenge even when we're not experiencing a pandemic," says study senior author Susan Carnell, Ph.D., associate professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine. "The pandemic has massively disrupted families and caused a lot of stress, and this has naturally affected interactions around food."

In the Johns Hopkins Medicine study, 318 parents of children ages 2-12 answered survey questions about interactions with their children regarding meals and snacks, and their youngsters' diets during the pandemic. During the survey, parents were asked about stress related to the COVID-19 pandemic, pre-COVID-19 stress, financial stress (e.g. food insecurity), their feeding practices as parents and how frequently children ate snacks.

The results showed that parents who reported higher levels of stress due to the pandemic also were more likely to use food to manage children's emotions and behaviors. For example, they might offer less nutritious food and snacks, such as cookies, as rewards. These findings are consistent with those of previous research studies showing that parental stress levels and a family's inadequate access to food impact the behaviors of parents when feeding their kids. COVID-19-specific stress also was linked to children eating more sweet and savory snacks throughout the day.

However, other results suggest positive effects of pandemic disruption. For example, the researchers say that 75% of families reported their children had regular breakfast, lunch and dinner times, and less consistent snack times. Lower reported stress also was associated with consistent mealtimes and routines, and positive interactions regarding food, such as parents eating or engaging with their children around mealtimes. This, the researchers say, likely reflects the effects of parents and children spending more time at home and having more chances to interact regarding food.

"The pandemic seems to have produced both negative and positive impacts on food parenting practices," says study lead author Elena Jansen, Ph.D., a postdoctoral fellow in psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine. "We look forward to learning how new routines will become habitual as the pandemic progresses."

To help ensure healthier children during the COVID-19 pandemic and beyond, the researchers recommend that parents follow proven practices, such as establishing regular meal times, involving children in meal preparation, arranging to eat together as a family without television and other distractions, modeling healthy eating habits for children, and being responsive to the hunger and fullness levels of their children when offering food.

The researchers say their ongoing research across socioeconomically diverse families will investigate how parent-child mealtime interactions and child snack intake evolve as the pandemic continues and eventually resolves.

Carnell and Jansen are available for interviews.

Credit: 
Johns Hopkins Medicine

When push comes to shove, what counts as a fight?

image: Monk parakeets are gregarious colonial-nesting birds that live in a social hierarchy. They are invasive species in the United States.

Image: 
Michael Miller

Biologists often study animal sociality by collecting observations about several types of behavioral interactions. These interactions can be things like severe fights, minor fights, cooperative food sharing, or grooming each other.

But to analyze animal behavior, researchers need to make decisions about how to categorize these interactions and how to code these behaviors during data collection. Turns out, this question can be complicated.

Researchers at the University of Cincinnati dug into this tricky question while studying monk parakeets. In new research, published in the journal Current Zoology, the team asked: How do you properly categorize two seemingly similar behaviors? The study was led by UC postdoctoral researcher Annemarie van der Marel who worked with UC PhD students Sanjay Prasher, Claire O'Connell, and Chelsea Carminito and UC Assistant Professor Elizabeth Hobson.

"Biologists have to deal with this question: are the behaviors that we categorize as unique actually perceived as unique by the animals?" Hobson said. "How do the animals classify those behaviors?"

Biases can easily lead researchers astray in making these judgement calls. "If you look at chimpanzees, smiling is an aggressive behavior. But in humans, smiling is friendly," said van der Marel. "The behaviors look similar to us but the nuances of how the behaviors are used are very different."

Monk parakeets are highly social parrots that live in large colonies where they often interact with other individuals. The parakeets spend a large proportion of the day fighting, especially top-ranked birds, which makes it easy to distinguish them from birds ranked lower in the dominance hierarchy, said O'Connell. The birds demonstrate aggression in many ways. They bite, of course. But monk parakeets also like to take another parrot's perch through menace or sheer force.

UC biologists observed two types of this "king of the hill" behavior: "displacements", where one bird lunges at another bird and can bite to force that bird away, and "crowding", where a threatened bird moves before an aggressor is within biting range. The team coded these behaviors as distinct because they appeared to differ in the level of aggression, with displacements appearing as a more severe form of aggression with a higher potential for injury. 

The parakeets also used these behaviors somewhat differently, with displacements occurring much more often than the crowding.

The question is: were these behaviors essentially used in the same ways by the birds, so that they could be treated as the same types of events in later analyses?

Pooling two behaviors has major research benefits such as creating a richer dataset for future analyses. But pooling also carries a risk -- by generalizing, scientists could be losing nuances of behaviors that convey important information when considered alone, Hobson said.

To get to the bottom of this question, the team turned to computational analysis. They created a new computer model that compared the real aggression patterns to ones that were randomized. This approach allowed the team to test whether treating the two behaviors as interchangeable caused any changes in the social structure. "On top of being a great lab bonding experience, it was an exciting opportunity to learn how to use simulations to help answer research questions" Prasher said.

In the UC study, their computational analysis supported pooling the two behaviors. For the UC team, these results will help them plan their future analyses as they work to understand the complex social lives of these parakeets. More broadly, van der Marel said the new framework can also help other animal-behavior researchers make informed and data-driven decisions about when to pool together behaviors and when to separate them.

Credit: 
University of Cincinnati

Mouse study identifies novel compound that may help develop diabetes drugs

image: Dr. Rama K. Mallampalli is professor and chair of the Department of Internal Medicine at The Ohio State University Wexner Medical Center and The Ohio State University College of Medicine.

Image: 
The Ohio State University Wexner Medical Center

COLUMBUS, Ohio - Research led by The Ohio State University Wexner Medical Center and College of Medicine identified a new compound that might serve as a basis for developing a new class of drugs for diabetes.

Study findings are published online in the journal Nature Chemical Biology.

The adenosine monophosphate-activated protein kinase (Ampk) is a crucial enzyme involved in sensing the body's energy stores in cells. Impaired energy metabolism is seen in obesity, which is a risk factor for diabetes. Some medications used to treat diabetes, such as metformin, work by increasing the activity of Ampk.

"In our study, we discovered a protein that is involved in removing Ampk from cells called Fbxo48. We designed and tested a compound termed, BC1618, that blocks Fbxo48 and was much more potent than metformin in increasing Ampk function. BC1618 improved responses to insulin, a measure of effectiveness for diabetes medicines, in obese mice," said Dr. Rama K. Mallampalli, senior author and chair of the department of internal medicine at Ohio State.

Mallampalli began this research at The University of Pittsburgh before joining Ohio State, and continued collaborating with researchers there to complete the study.

"This study builds on our prior research to understand how critical proteins in the body are removed or degraded. The research team had previously designed and produced a family of anti-inflammatory drugs that are FDA approved and are poised to enter Phase 1 studies," Mallampalli said. "Using this new compound as a backbone, our team including Dr. Bill Chen and Dr. Yuan Liu at Pittsburgh will make other compounds that are more potent and safe in animal models and then test them in diabetes animal models. Eventually we aim to obtain FDA approval for human testing."

Credit: 
Ohio State University Wexner Medical Center

Study sheds new light on the behaviour of the giant carnivorous dinosaur Spinosaurus

image: Reconstructed skeleton of a moderately sized Spinosaurus showing its famous sail-back and tail plume. Scale bar is 1 m.

Image: 
Image by Genya Masukawa who retains the copyright but this is free to use in conjunction with this story.

New research from Queen Mary University of London and the University of Maryland, has reignited the debate around the behaviour of the giant dinosaur Spinosaurus.

Since its discovery in 1915, the biology and behaviour of the enormous Spinosaurus has puzzled palaeontologists worldwide. It was recently argued that the dinosaur was largely an aquatic predator, using its large tail to swim and actively pursue fish in the water.

The new study, published today in Palaeontologia Electronica, challenges this recent view of Spinosaurus suggesting that whilst it likely fed from the water, and may have swum, it wasn't well adapted to the life of an aquatic pursuit predator. Instead it was like a giant (if flightless) heron or stork - snatching at fish from the shoreline while also taking any other small available prey on land or in water.

The researchers compared the features of Spinosaurus with the skulls and skeletons of other dinosaurs and various living and extinct reptiles that lived on land, in the water or did both. They found that whilst there were several pieces of evidence that contradicted the aquatic pursuit predator concept, none contradicted the wading heron-like model, and various lines of evidence actively supported it.

Dr David Hone, Senior Lecturer at Queen Mary and lead author on the project said: "The biology and ecology of Spinosaurus has been troubling palaeontologists for decades. Some recent studies have suggested that it was actively chasing fish in water but while they could swim, they would not have been fast or efficient enough to do this effectively. Our findings suggest that the wading idea is much better supported, even if it is slightly less exciting."

Co-author Tom Holtz, Principal Lecturer in Vertebrae Paleontology, University of Maryland, said: "Spinosaurus was a bizarre animal even by dinosaur standards, and unlike anything alive today, so trying to understand its ecology will always be difficult. We sought to use what evidence we have to best approximate its way of life. And what we found did not match the attributes one would expect in an aquatic pursuit predator in the manner of an otter, sea lion, or short-necked plesiosaur."

One of the key pieces of evidence unearthed by the researchers related to the dinosaur's ability to swim. Spinosaurus was already shown to be a less efficient swimmer than a crocodile, but also has fewer tail muscles than a crocodile, and due to its size would have a lot more drag in the water.

Dr Hone said: "Crocodiles are excellent in water compared to land animals, but are not that specialised for aquatic life and are not able to actively chase after fish. If Spinosaurus had fewer muscles on the tail, less efficiency and more drag then it's hard to see how these dinosaurs could be chasing fish in a way that crocodiles cannot."

Dr Holtz added: "We certainly add that the evidence points to Spinosaurus feeding partly, even mostly, in the water, probably more so than any other large dinosaur. But that is a different claim than it being a rapid swimmer chasing after aquatic prey." Though as Dr Hone concludes: "Whilst our study provides us with a clearer picture of the ecology and behaviour of Spinosaurus, there are still many outstanding questions and details to examine for future study and we must continue to review our ideas as we accumulate further evidence and data on these unique dinosaurs. This won't be the last word on the biology of these amazing animals."

Originally found in Egypt, Spinosaurus is thought to be one of the largest carnivorous dinosaurs to exist probably reaching over 15 m in length. The first known Spinosaurus fossils were destroyed by Allied bombing during World War II, which has hampered palaeontologist's attempts to understand these unusual creatures. More recently the dinosaur found fame in the 2001 film Jurassic Park III, where it battles and defeats a Tyrannosaurus rex.

Credit: 
Queen Mary University of London

Can dogs rapidly learn words?

image: The Family Dog Project research team is investigating on these exceptionally talented dogs

Image: 
Photo by Claudia Fugazza

A new study found that talented dogs can learn new words after hearing them only four times.

While preliminary evidence seems to show that most dogs do not learn words (i.e. names of objects), unless eventually very extensively trained, a few individuals have shown some exceptional abilities.

The Family Dog Project research team at the Department of Ethology, Eötvös Loránd University, Budapest is investigating on these exceptionally talented dogs who seem to learn words in the absence of any formal training, but simply by being exposed to playing with their owners in the typical way owners do, in a human family.

Video abstract of the study: https://youtu.be/Wr_P5NR1A3k

A new study, just published in Scientific Reports, has provided surprising results about how quickly the gifted dogs can learn new words. Two gifted dogs, a Border Collie named Whisky, from Norway, already famous for her spontaneous categorization skills and a Yorkshire terrier named Vicky Nina, from Brazil, participated in this experiment. Their ability to learn a new word after hearing it only four times was tested.

While it is natural to think that dogs, like human children, would learn words mostly in a social context, previous studies tested the ability of talented dogs to learn object names during an exclusion-based task. In such task the dog was confronted with a setup in which seven familiar, already named dog toys were present, together with a novel one and his ability to choose the novel object upon hearing a novel name was tested.

"We wanted to know under which conditions the gifted dogs may learn novel words. To test this, we exposed Whisky and Vicky Nina to the new words in two different conditions" explains Claudia Fugazza, first author of the study, "during an exclusion-based task and in a social playful context with their owners. Importantly, in both conditions the dogs heard the name of the new toy only 4 times".

In the exclusion-based task, the dogs showed that they were able to select the new toy when their owner spoke a new name, confirming that dogs can choose by exclusion - i.e., excluding all the other toys because they already have a name, and selecting the only one that does not. However, this was not the way they would learn the name of the toy. In fact, when tested on their ability to recognize the toy by its name, as this was confronted with another equally novel name, the dogs failed.

The other condition, the social one, where the dogs played with their owners who pronounced the name of the toy while playing with the dog, proved to be the successful way to learn the name of the toy, even after hearing it only 4 times. Whisky and Vicky Nina were able to select the toys based on their names when they had learned the names this way.

"Such rapid learning seems to be similar to the way human children acquire their vocabulary around 2-3 years of age", comments Adam Miklósi, head of the Department of Ethology and co-author of the study.

To test whether most dogs would learn words this way, other 20 dogs were tested in the same condition, but none of them showed any evidence of learning the toy names, confirming that the capacity to learn words rapidly, in the absence of formal training is very rare and is only present in few gifted dogs.

After such few exposures, however, Whisky's and Vicky Nina's memory of the learned words decayed quite fast. While in the first test, conducted a couple of minutes after hearing the toy names, the dogs were successful, they did not succeed in most of the tests conducted after 10 minutes and 1 hour.

To find out more about the number of words that the gifted dogs can learn in a short timeframe, the researchers of Eötvös Loránd University have also recently launched the Genius Dog Challenge a project that became viral in the social media.

Vicky Nina, unfortunately, passed away in the meantime and could not take part in the Genius Dog Challenge. Whisky is participating in it, together with other five talented dogs that the scientists found all over the world in the past two years of search.

Credit: 
Eötvös Loránd University

Toddlers who use touchscreens may be more distractible

Toddlers with high daily touchscreen use are quicker to look at objects when they appear and are less able to resist distraction compared to toddlers with no or low touchscreen use - according to new research from Birkbeck, University of London, King's College London and University of Bath.

The research team say the findings are important for the growing debate around the role of screen time on toddlers' development especially given the increased levels of screen time seen during the COVID-19 pandemic.

Lead researcher Professor Tim Smith, from Birkbeck's Centre for Brain and Cognitive Development, said: "The use of smartphones and tablets by babies and toddlers has accelerated rapidly in recent years. The first few years of life are critical for children to learn how to control their attention and ignore distraction, early skills that are known to be important for later academic achievement. There has been growing concern that toddler touchscreen use may negatively impact their developing attention but previously there was no empirical evidence to support this."

To provide such evidence, Professor Smith's TABLET Project, at Birkbeck's Centre for Brain and Cognitive Development, recruited 12-month-old infants who had different levels of touchscreen usage. The study followed them over the next 2.5 years, bringing them into the lab three times, at 12 months, 18 months and 3.5 years. During each visit the toddlers took part in computer tasks with an eye-tracker to measure their attention. Objects appeared in different screen locations. How quickly toddlers looked at the objects and how well they could ignore distracting objects were measured.

Professor Smith states: "We found that infants and toddlers with high touchscreen use were faster to look at objects when they appeared and were less able to ignore distracting objects compared to the low users."

Dr Ana Maria Portugal, main researcher on the project points out "We are currently unable to conclude that the touchscreen use caused the differences in attention as it could also be that children who are more distractible may be more attracted to the attention-grabbing features of touchscreen devices than those who are not."

Co-investigator Dr Rachael Bedford, from the Department of Psychology at University of Bath commented: "What we need to know next is how this pattern of increased looking to distracting objects on screens relates to attention in the real-world: is it a positive sign that the children have adapted to the multitasking demands of their complex everyday environment or does it relate to difficulties during tasks that require concentration?"

Credit: 
University of Bath

Highly specific synaptic plasticity in addiction

image: One step of the methodology used to isolate and measure the MMP activity.

Image: 
Elsevier

Philadelphia, January 26, 2021 - Addiction, or substance use disorder (SUD), is a complex neurological condition that includes drug-seeking behavior among other cognitive, emotional and behavioral features. Synaptic plasticity, or changes in the way neurons communicate with one another, drives these addictive behaviors. These lasting brain changes are at the crux of why addiction is so hard to treat.

A new study in Biological Psychiatry, published by Elsevier, now shows that players in the extracellular environment - not just at neuronal interfaces - contribute to addiction plasticity. Neurons in a brain area called the nucleus accumbens are known to undergo addiction-related plasticity. Specifically, changes at synapses of medium spiny neurons (MSN), which sense the neurotransmitter dopamine, have been associated with drug-seeking and extinction behaviors.

Previous research had shown that plasticity at MSNs expressing the D1-type of dopamine receptor is linked to drug-seeking, whereas extinction of drug-seeking involves plasticity at MSNs containing the D2-type dopamine receptor. Now, research led by Peter Kalivas, PhD, and Vivian Chioma, PhD, shows that distinct enzymes working at D1- and D2-type MSNs underlie drug-seeking and extinction behaviors.

The researchers trained rats to self-administer heroin by pushing a lever for 10 days, followed by a 10-day withdrawal period. They then carefully examined the rats' brains under a microscope to detect enzymatic activity around the MSN synapses.

The study focused on the activity of extracellular enzymes called metalloproteinases (MMP). MMPs break down proteins that constitute the extracellular matrix around nerve cells. This matrix of proteins supports synaptic connections, but it also constrains the remodeling of synaptic connections in response to experience. Therefore, MMP activity directly impacts cells' ability to manifest neuroplastic changes.

To assess activity of the MMPs, the researchers used a technique called in vivo zymography, in which the rats' brains were injected with a fluorescent dye encapsulated in a protective gelatin coat at various points during the drug-training regimen. Once broken open by MMP enzymes, the dye becomes visible, allowing the investigators to observe cells' morphology as well as the enzymes' activity around specific cell types and sub-cellular locations.

"We found that drug cues increased MMP activity on one cell type in the nucleus accumbens," said Dr. Kalivas, referring to D1-type MSNs, "and they decreased activity on another cell type," the D2-type MSNs. "By showing this cellular specificity of MMP activation and inactivation by cues, we have identified novel molecules that may be potential targets for drug development in treating drug addiction," he added.

"This paper highlights the exquisite selectivity of addiction-related neuroplasticity," said John Krystal, MD, Editor of Biological Psychiatry. "In this study, cues associated with heroin delivery activated MMPs near dopamine D1 receptor-containing MSNs in the nucleus accumbens, promoting plasticity in key cells implicated in addiction. Rather than reducing this addiction-related effect on plasticity, extinction training instead increased MMP activity close to neighboring dopamine D2 receptor-containing MSNs – cells implicated in protection against addiction."

Importantly, the researchers also saw MMP activity associated with cells adjacent to the MSNs called astrocytes, a type of glial cell. The astrocytes, the extracellular matrix, and the two neurons forming a synapse are all part of what is termed the tetrapartite, or four-part, synaptic complex.

"Our work investigating cell-type specific synaptic neuroadaptations in the nucleus accumbens provides evidence of novel advances in our understanding of tetrapartite synaptic activity during heroin seeking," said Dr. Chioma. "This research demonstrates how integration of components of the tetrapartite synapse regulate specific addiction phenotypes."

Dr. Krystal added, "This finding suggests that recovery from addiction is not simply a reversal of addiction-related changes in the brain, but rather it also involves the laying down of new anti-addiction changes that protect against substance use."

Credit: 
Elsevier

How did Florida fail to respond to a coral disease epizootic and what's to follow?

image: A colony of the large grooved brain coral, Colpophyllia natans, infected by Stony Coral Tissue Loss Disease. The photo shows the progressive, rapid advance of disease, left-to-right, across the colony.

Image: 
William Precht

By 2020, massive losses of large populations of corals have been observed throughout Florida and into the greater Caribbean basin. Taking into account the high mortality and the large number of susceptible species affected, this is likely the most lethal case of Stony Coral Tissue Loss Disease (SCTLD) ever recorded in modern history.

However, for too long, the tremendous decline in coral reefs has wrongly been attributed to the local dredge project, which had been ongoing at the time of the initial reports. In a recent Perspectives paper, published in the open-access peer-reviewed journal Rethinking Ecology, William Precht, a carbonate sedimentologist by training and currently the Director of Marine and Coastal Programs for the independent environmental consulting firm Dial Cordy and Associates Inc., provides an overview about what went wrong and how Florida ended up in a situation, where the best that could be done is the rescue of genetic material from coral species already at risk of regional extinction.

In fact, the coral disease was first observed in September 2014 near Virginia Key, Florida, and is, unfortunately, still active throughout the Caribbean to this date.

Initially, the resource managers in Southeast Florida missed the short time window to respond to the emerging epidemic before it spreads. Once it began to reach into the greater Caribbean, many, including the mass media, were quick to blame the ongoing Port Miami Dredge Project for the coral reef losses, even though its activities, meant to widen or deepen existing ship channels, while minimising damage to coral reef resources, had already been under a thorough scrutiny by government agencies and intensive monitoring, conducted by trained scientific divers. Nevertheless, dredging has typically been assumed to be bad for corals. Furthermore, these events coincided with the State of Florida's prohibition for government employees to acknowledge global warming in their work.

In the meantime, SCTLD, a disease initiated by a regional thermal anomaly and coral bleaching event, was killing off the same suite of coral species in the same fashion throughout the region, well beyond the dredge site.

"Finally, when the agencies responded to the outbreak, their efforts were too little and much too late to make a meaningful difference. While eradication of the disease was never a possibility, early control measures may have slowed its spread, or allowed for the rescue of significant numbers of large colonies of iconic species. Because of the languid management response to this outbreak, we are now sadly faced with a situation where much of our management efforts are focused on the rescue of genetic material from coral species already at risk of regional extinction," explains Precht.

"Why was the response to the loss of our coral reefs to a coral disease epidemic such a massive failure? This includes our failure as scientists, regulators, resource managers, local media, and policy makers alike," he adds.

Credit: 
Pensoft Publishers

Breakthrough design at UBCO vastly improves mechanical heart valve

image: Associate Professor Hadi Mohammadi is the lead researcher at UBCO's Heart Valve Performance Lab.

Image: 
UBCO

New research coming out of UBC's Okanagan campus may take the current 'gold standard' for heart valves to a new level of reliability.

A team of researchers at UBCO's Heart Valve Performance Lab (HVPL) has developed a way to improve overall blood flow through the valves, so the design of mechanical heart valves will more closely match the real thing.

"Despite more than 40 years of research, we are still chasing the goal of creating mechanical heart valves that perform consistently and seamlessly inside the human body," explains Dr. Hadi Mohammadi, an associate professor at the School of Engineering and lead researcher for the HVPL. "The way blood travels through the body is very unique to a person's physiology, so a 'one-size fits all' valve has always been a real challenge."

Mohammadi, along with doctoral student Arpin Bhullar, has developed an innovative mechanical bileaflet that enables the mechanical heart valve to function just like the real thing. A bileaflet valve--two semicircular leaflets that pivot on hinges--is a mechanical gateway that allows consistent blood-flow and ensures the flow is in one direction.

While developed decades ago and used regularly to improve a patient's blood flow, artificial valves have never been perfect, says Mohammadi. With existing versions of bileaflets, there is a small risk of blood clots or even a backflow of blood.

The design of the bileaflet is crucial for maintaining blood flow in order to eliminate risk to the patient. Mohammadi believes he's found a way to fix the problem, by adding a slight twist to the design.

"Our findings show our apex heart valve maintains consistent flow as a result of its breakthrough design--specifically the valve's curvature which mitigates clotting."

The initial design was confirmed by Dr. Guy Fradet, head of Kelowna General Hospital's cardiothoracic surgery program. Mohammadi says it takes decades for innovations in mechanical heart valves before they are used on humans, but he is confident his novel leaflet-shaped valve is the way of the future.

"The work we're doing has resulted in the design of a valve which may serve as the foundation for the next generation of bileaflet mechanical heart valves," he says. "Our research, with computer simulation and in-vitro studies, helped evaluate the performance of the proposed valve and also compare it to the industry gold standard."

Credit: 
University of British Columbia Okanagan campus

Research shows people with high omega-3 index less likely to die from COVID-19

Researchers with the Fatty Acid Research Institute (FARI) and collaborators at Cedars-Sinai Medical Center in Los Angeles and in Orange County, CA, have published the first direct evidence that higher omega-3 blood levels may reduce risk for death from COVID-19 infection. The report was published in the journal Prostaglandins, Leukotrienes and Essential Fatty Acids on January 20, 2021.

There are several papers in the medical literature hypothesizing that omega-3 fatty acids should have beneficial effects in patients with COVID-19 infection, but up until now, there have been no published peer-reviewed studies supporting that hypothesis.

This study included 100 patients admitted to the hospital with COVID-19 for whom admission blood samples had been stored. Clinical outcomes for these patients were obtained and blood was analyzed for the Omega-3 Index (O3I, red blood cell membrane EPA+DHA levels) at OmegaQuant Analytics (Sioux Falls, SD). Fourteen of the patients died.

The 100 patients were grouped into four quartiles according to their O3I, with 25% of the patients in each quartile. There was one death in the top quartile (i.e., 1 death out of 25 patients with O3I>5.7%), with 13 deaths in the remaining patients (i.e., 13 deaths out of 75 patients with O3I

In age-and-sex adjusted regression analyses, those in the highest quartile (O3I >5.7%) were 75% less likely to die compared with those in the lower three quartiles (p=0.07). Stated another way, the relative risk for death was about four times higher in those with a lower O3I (

"While not meeting standard statistical significance thresholds, this pilot study - along with multiple lines of evidence regarding the anti-inflammatory effects of EPA and DHA - strongly suggests that these nutritionally available marine fatty acids may help reduce risk for adverse outcomes in COVID-19 patients. Larger studies are clearly needed to confirm these preliminary findings," said Arash Asher, MD, the lead author on this study.

Agreeing with Dr. Asher, cardiology researcher and co-developer with Dr. Harris of the Omega-3 Index, Clemens von Schacky, MD, (CEO, Omegametrix GmbH, Martinsried, Germany, and not involved with the study) said, "Asher et al have demonstrated that a low Omega-3 Index might be a powerful predictor for death from COVID-19. Although encouraging, their findings clearly need to be replicated."

Omega-3 expert James H. O'Keefe, Jr., MD, (Director of Preventive Cardiology, Saint Luke's Mid America Heart Institute, Kansas City, MO, and also not involved with the study) observed, "An excessive inflammatory response, referred to as a 'cytokine storm,' is a fundamental mediator of severe COVID-19 illness. Omega-3 fatty acids (DHA and EPA) have potent anti-inflammatory activities, and this pilot study provides suggestive evidence that these fatty acids may dampen COVID-19's cytokine storm."

The FARI research team is currently seeking funding to expand upon these preliminary observations. Individuals and organizations that want to support this research are encouraged to visit FARI's donations page.

Credit: 
Wright On Marketing & Communications

Mental health is important to overall health, and heart disease prevention and treatment

DALLAS, Jan. 25, 2021 — Psychological health can positively or negatively impact a person’s health and risk factors for heart disease and stroke, according to “Psychological Health, Well-Being, and the Mind-Heart-Body Connection,” a new American Heart Association Scientific Statement, published today in the Association’s flagship journal Circulation. The statement evaluates the relationship between psychological health and heart health, summarizing ways to help improve psychological health for people with and at risk for heart disease.

“A person’s mind, heart and body are all interconnected and interdependent in what can be termed ‘the mind-heart-body-connection,’” said Glenn N. Levine, M.D., FAHA, master clinician and professor of medicine at Baylor College of Medicine, chief of the cardiology section at the Michael E. DeBakey VA Medical Center, both in Houston, and chair of the writing committee for the Scientific Statement. “Research has clearly demonstrated that negative psychological factors, personality traits and mental health disorders can negatively impact cardiovascular health. On the other hand, studies have found positive psychological attributes are associated with lower risk of cardiovascular disease and mortality.”

Negative psychological health conditions include depression, chronic stress, anxiety, anger, pessimism and dissatisfaction with one’s current life. These conditions are associated with potentially harmful biological responses, such as:

irregularities of heart rate and rhythm;
increased digestive complaints;
increased blood pressure;
inflammation; and
reduced blood flow to the heart.

Negative psychological health is also associated with health behaviors that are linked to an increased risk for heart disease and stroke, such as smoking, lower levels of physical activity, unhealthy diet, being overweight and not taking medications as prescribed.

Due to evidence that connects negative psychological health to heart disease, the statement suggests regular mental health screening for people with or at risk for cardiovascular disease. The authors note that psychological therapy and mind-body programs can lead to better cardiovascular health. Programs that improve psychological health include cognitive behavioral therapy, psychotherapy, collaborative care management approaches, stress reduction therapy and meditation.

The Statement highlights research showing that both the cumulative effect of daily stressors and exposure to traumatic events can also increase the risk of heart disease and stroke. Patients’ self-report of general stress as well as work-related stress have been associated with an up to 40% increased risk of developing or dying from heart disease.

“Most studies of psychological health are observational, with many involving self-reporting from patients, which presents challenges to establishing specific cause and effect relationships,” said Levine. “However, a preponderance of such studies is highly suggestive and allows one to make reasonable conclusions about an association between negative psychological health and cardiovascular risk.”

On the other hand, studies have found positive psychological health associated with a lower risk of cardiovascular disease and death. Positive psychological health characteristics include happiness, optimism, gratitude, sense of purpose, life satisfaction and mindfulness. “The data is consistent, suggesting that positive psychological traits play a part in better cardiovascular health,” said Levine.

People with positive psychological health were also more likely to have health factors linked to a lower risk of developing cardiovascular disease:

lower blood pressure;
better glucose control;
less inflammation; and
lower cholesterol.

Positive psychological health is also associated with beneficial health behaviors such as smoking cessation, increased physical activity, heart-healthy eating, increased medication adherence and regular check-ups and health screenings.

Also, said Levine, social factors may further influence cardiovascular health. People with better mental health tend to have positive social relationships, support and connections, which can facilitate healthier adaptation to life’s challenges.

Levine adds, “Wellness is more than simply the absence of disease. It is an active process directed toward a healthier, happier and more fulfilling life, and we must strive to reduce negative aspects of psychological health and promote an overall positive and healthy state of being. In patients with or at risk for heart disease, health care professionals need to address the mental wellness of the patient in tandem with the physical conditions affecting the body, such as blood pressure, cholesterol levels, chest pain, etc.”

This Scientific Statement was prepared by the volunteer writing group on behalf of the American Heart Association’s Council on Clinical Cardiology; the Council on Arteriosclerosis, Thrombosis and Vascular Biology; the Council on Cardiovascular and Stroke Nursing; and the Council on Lifestyle and Metabolic Health.

Credit: 
American Heart Association

Despite some advances, women still face disparities of the global burden of stroke

DALLAS, Jan. 25, 2021 — The continued global burden of stroke and how it disproportionately affects women are highlighted in new science published online today in the February issue of Stroke, a journal of the American Stroke Association, a division of the American Heart Association. Stroke editors selected nine manuscripts focused on stroke disparities in women in this collaboration with Go Red for Women®, the Association’s global movement to end heart disease and stroke in women.

“Stroke continues to be a leading cause of death and disability worldwide, with women being more adversely affected by the global burden of stroke,” said Stroke Editor-In-Chief Ralph L. Sacco, M.D., M.S., FAHA, a past president of the American Heart Association. “As our population ages, the number of stroke survivors will continue to rise, especially among women. We must include more women in stroke research so we can enhance the critical evidence necessary to provide the appropriate stroke treatments needed to save and improve lives.”

Worldwide, stroke is the second leading cause of death. More than 101 million people have a stroke each year, and more than 6.6 million people die of a stroke, annually. About 1 in 4 stroke survivors will experience another stroke within five years.

“The papers highlighted in this issue feature international research and perspective from more than half a dozen countries,” said Sacco, chair of the department of neurology, the Olemberg Family Chair in Neurological Disorders and executive director of the Evelyn F. McKnight Brain Institute at the University of Miami Leonard Miller School of Medicine, in Miami, Florida. “This collective work from some of the most renowned scientists in the field offers important insight, recommendations and guidance for addressing this critical topic.”

Two of the studies addressed concerns about the lack of women in stroke clinical trials, thus limiting information to ensure appropriate stroke treatment for women, which has long been an issue for scientists.

Why Are Women Less Represented in Intracerebral Hemorrhage Trials? - Tatiana Greige et al.  Researchers examined the different reasons men and women were excluded from a major trial about treatment for hemorrhagic, or bleeding, strokes.

The intracerebral hemorrhage DEFeroxamine (iDEF) trial was a prospective, multicenter, randomized, placebo-controlled, double-blind, phase 2 trial that evaluated the use of deferoxamine mesylate versus placebo (saline) infusions in patients with hemorrhagic strokes at 40 hospitals in Canada and the U.S. While iDEF included 293 participants, only 38.2% of participants were women. The major reason for this disparity was the exclusion of participants over the age of 80 — 22.4% of women were not included in the trial for this reason versus 12.61% of men.

The under-enrollment of women in stroke clinical trials: What are the causes and what should be done about it? - Cheryl Carcel; Matthew Reeves

Addressing the age barrier to stroke research is one of several recommendations offered in a commentary of presentations made at the European Stroke Organization-World Stroke Organization 2020 virtual conference. The authors noted that discrepancies in the enrollment of women in stroke clinical trials raises concerns about the generalizability of trial results, as well as the potential for reduced access and use of new therapies in women. Their recommendations for addressing this include:

More research, both quantitative and qualitative, should be undertaken to identify the causes and barriers to enrolling women in stroke clinical trials, particularly to understand how the attitudes and beliefs of women towards research and health in general may be impacting their participation in studies.
Stroke trials should avoid using an upper age limit as an exclusion criterion (e.g., >80 years) since this has been shown to have a disproportionate effect on the number of women enrolled in trials.
Researchers should make greater efforts to collect appropriate data from trial screening logs to better identify specific factors that could help in understanding why women may be under-enrolled in stroke trials.
The number of trial investigators and research staff who are women should be increased and has the potential to create environments in which more women are enrolled in stroke clinical trials.

Below are highlights of some of the other manuscripts in this issue, which can be accessed in full here.

Sex, age, and socioeconomic differences in non-fatal stroke incidence and subsequent major adverse outcomes - Ralph K. Akyea et al.

Researchers for this large cohort study used data from the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES) to assess stroke incidence in the general population of the United Kingdom from 1998-2019. During this time, 82,774 people survived a stroke, of which 44,614 (53.9%) were women. Men in the study experienced stroke at a younger age compared to women (71.4 vs 76.9 years, respectively). Men ages 30-74 years had higher stroke incidence rates compared to women; however, among those ages 75 and older, the incidence rates were much higher in women.

The rate of stroke incidence among people ranked in the lowest ranking of socioeconomic status was 10% higher than the rate in the highest socioeconomic status rank. Those rankings were based on such factors as income; employment; education, skills and training; health and disability; crime; barriers to housing and services; and living environment.

The researchers also examined a subset of 68,877 stroke survivors who had not had previous complications. Of those:

47,500 eventually had a major adverse cardiovascular event, 25,731 were women (68.8% of all the female survivors);
33,831 had another stroke (more than 52% were women);
20,335 died of any cause (more than 59% were women); and
9,174 died of cardiovascular complications (more than 61% were women).

The researchers noted their findings show a higher burden of major adverse outcomes (such as a cardiovascular event, stroke or death) observed in women when compared to men after first non-fatal stroke is largely accounted for by age and socioeconomic status.

Advances in Stroke: Stroke in Women - Moira K. Kapral et al.

This paper highlights recent advances in the understanding of sex differences in the benefits of endovascular therapy, outcomes after stroke and the potential to prevent stroke in women with a history of hypertensive disorders of pregnancy. This perspective paper includes data analysis from several clinical trials. The researchers found:

The relatively new treatment of mechanical removal of a blood clot, known as endovascular therapy (EVT), was associated with similar functional independence in women and men. Additionally, women had a nearly two-year gain in disability-adjusted life years after EVT compared to men, and women and men had similar 90-day mortality, functional independence, safety outcomes and successful restoration of blood flow to the brain. The researchers noted that while many clinical trials of EVT tended to exclude older women with pre-stroke disability and comorbid conditions, the results of their analysis point to this treatment being equally beneficial for men and women.
The authors identified numerous instances of women having worse stroke outcomes than men – and women had higher rates of death, disability and quality of life, much of which can be attributed to age, stroke severity, pre-stroke function capacity and depression. They suggest targets for interventions could include efforts to reduce stroke severity (e.g., through management of stroke risk factors), address mood disorders (e.g., through routine screening and treatment) and optimize functional status and quality of life (e.g., through rehabilitation).
Another analysis found women are less likely than men (67.8% vs. 76.8%) to be diagnosed with stroke or cerebrovascular event, and there is less investigation into the causes of stroke among women. The authors noted these results are consistent with previous research, and the lack of cause identification and the management of vascular risk factors could have dangerous consequences.
The researchers also analyzed findings from the California Teachers Study that found the risk of stroke before age 60 was modified by aspirin use in women with hypertensive disorders of pregnancy. Women who did not use aspirin had an increased risk of stroke, while those on aspirin therapy did not. The authors noted the fact that aspirin can prevent preeclampsia when taken during pregnancy suggests an interesting link for aspirin use, hypertensive disorders of pregnancy and ischemic stroke risk beyond child-bearing years. These findings are also consistent with prior studies that have identified hypertensive disorders of pregnancy as a risk factor for subsequent stroke, and the authors suggest that aspirin could be a target for future controlled trials for stroke prevention.

The other studies in this special issue include:

The female stroke - sex differences in acute treatment and early outcomes of acute ischemic stroke – Anna Bonkhoff et al.
Absence of consistent sex differences in outcomes from symptomatic carotid endarterectomy and stenting trials – Virginia Howard et al.
Influence of pregnancy on hemorrhage risk in women with cerebral and spinal cavernous malformations – Nycole Joseph et al.
Sex-related differences in clinical features, neuroimaging  and long-term prognosis after transient ischemic attack – Francisco Purroy et al.
Stroke incidence by sex across the lifespan – Manav Vyas et al.

Authors’ disclosures and funding sources for all studies in the special issue are listed in the individual manuscripts.

“We are pleased to publish this important research to enhance our understanding of the unique differences in the diagnosis, treatment and prevention of stroke in women,” Sacco said. “Our essential goal is to prevent stroke, reduce disability and ultimately save lives; education and awareness are critical first steps.”

To raise awareness about how participation in research could further scientific understanding of cardiovascular health, the American Heart Association and Verily, Alphabet’s life sciences and healthcare arm, have launched Research Goes Red. Research Goes Red aims to empower women to contribute to health research. Learn more at www.goredforwomen.org/en/get-involved/research/research-goes-red

Credit: 
American Heart Association

COVID-19 warnings were on Twitter well before the outbreak of the pandemic

Even before public announcements of the first cases of COVID-19 in Europe were made, at the end of January 2020, signals that something strange was happening were already circulating on social media. A new study of researchers at IMT School for Advanced Studies Lucca, published in Scientific Reports, has identified tracks of increasing concern about pneumonia cases on posts published on Twitter in seven countries, between the end of 2019 and the beginning of 2020. The analysis of the posts shows that the "whistleblowing" came precisely from the geographical regions where the primary outbreaks later developed.

To conduct the research, the authors first created a unique database with all the messages posted on Twitter containing the keyword "pneumonia" in the seven most spoken languages of the European Union - English, German, French, Italian, Spanish, Polish, and Dutch - from December 2014 until 1 March 2020. The word "pneumonia" was chosen because the disease is the most severe condition induced by the SARS-CoV-2, and also because the 2020 flu season was milder than the previous ones, so there was no reason to think it to be responsible for all the mentions and worries. The researchers then made a number of adjustments and corrections to the posts in the database to avoid overestimating the number of tweets mentioning pneumonia between December 2019 and January 2020, that is to say in the weeks between the World Health Organization (WHO) announcement that the first "cases of pneumonia of unknown etiology" had been identified - on 31 December 2019 - and the official recognition of COVID19 as a serious transmissible disease, on 21 January 2020. In particular, all the tweets and retweets containing links to news about the emerging virus were eliminated from the database to exclude from the count the mass media coverage of the emerging pandemic.

The analysis of the authors shows an increase in tweets mentioning the keyword "pneumonia" in most of the European countries included in the study as early as January 2020, such as to indicate an ongoing concern and public interest in pneumonia cases. In Italy, for example, where the first lock-down measures to contain COVID-19 infections were introduced on 22 February 2020, the increase rate in mentions of pneumonia during the first few weeks of 2020 differs substantially from the rate observed in the same weeks in 2019. That is to say that potentially hidden infection hotspots were identified several weeks before the announcement of the first local source of a COVID-19 infection (20 February, Codogno, Italy). France exhibited a similar pattern, whereas Spain, Poland, and the UK witnessed a delay of 2 weeks.

The authors also geo-localized over 13,000 pneumonia-related tweets in this same period, and discovered that they came exactly from the regions where the first cases of infections were later reported, such as the Lombardia region in Italy, Madrid, Spain, and Île de France.

Following the same procedure used for the keyword "pneumonia", the researchers also produced a new dataset containing the keyword "dry cough", one of the other symptoms later associated with the COVID-19 syndrome. Even then, they observed the same pattern, namely an abnormal and statistically significant increase in the number of mentions of the word during the weeks leading up to the surge of infections in February 2020.

"Our study adds on to the existing evidence that social media can be a useful tool of epidemiological surveillance. They can help intercept the first signs of a new disease, before it proliferates undetected, and also track its spread" says Massimo Riccaboni, full professor of Economics at the IMT School, who coordinated the research.

This is especially true in a situation like the current pandemic, when lapses in identifying early-warning signals left many national governments blind to the unprecedented scale of the looming public health emergency. In a successive phase of the pandemic, monitoring social media could help public health authorities mitigate the risks of contagion resurgence, for example by adopting stricter measures of social distancing where the infections appear to be increasing, or vice versa relaxing them in other regions. These tools could also pave the way to an integrated epidemiological surveillance system globally managed by international health organizations.

Credit: 
IMT School for Advanced Studies Lucca

Women influenced coevolution of dogs and humans

PULLMAN, Wash. - Man's best friend might actually belong to a woman.

In a cross-cultural analysis, Washington State University researchers found several factors may have played a role in building the mutually beneficial relationship between humans and dogs, including temperature, hunting and surprisingly - gender.

"We found that dogs' relationships with women might have had a greater impact on the dog-human bond than relationships with men," said Jaime Chambers, a WSU anthropology Ph.D. student and first author on the paper published in the Journal of Ethnobiology. "Humans were more likely to regard dogs as a type of person if the dogs had a special relationship with women. They were more likely to be included in family life, treated as subjects of affection and generally, people had greater regard for them."

While dogs are the oldest, most widespread domesticated animal, very few anthropologic studies have directly focused on the human relationship with canines. Yet when the WSU researchers searched the extensive collection of ethnographic documents in the Human Relations Area Files database, they found thousands of mentions of dogs.

Ultimately, they located data from more than 844 ethnographers writing on 144 traditional, subsistence-level societies from all over the globe. Looking at these cultures can provide insight into how the dog-human relationship developed, Chambers said.

"Our modern society is like a blip in the timeline of human history," she said. "The truth is that human-dog relationships have not looked like they do in Western industrialized societies for most of human history, and looking at traditional societies can offer a wider vision."

The researchers noted specific instances that showed dogs' utility, or usefulness, to humans, and humans' utility to dogs as well as the "personhood" of dogs--when canines were treated like people, such as being given names, allowed to sleep in the same beds or mourned when they died.

A pattern emerged that showed when women were more involved with dogs, the humans' utility to dogs went up, as did the dogs' personhood.

Another prevalent trend involved the environment: the warmer the overall climate, the less useful dogs tended to be to humans.

"Relative to humans, dogs are really not particularly energy efficient," said Robert Quinlan, WSU anthropology professor and corresponding author on the paper. "Their body temperature is higher than humans, and just a bit of exercise can make them overheat on a hot day. We saw this trend that they had less utility to humans in warmer environments."

Quinlan noted there were some exceptions to this with a few dog-loving cultures in the tropics, but it was a fairly consistent trend.

Hunting also seemed to strengthen the dog-human connection. In cultures that hunted with dogs, they were more valued by their human partners: they were higher in the measures of dogs' utility to humans and in personhood. Those values declined, however, when food production increased whether it was growing crops or keeping livestock. This finding seemed to go against the commonly held perception of herding dogs working in concert with humans, but Quinlan noted that in many cultures, herding dogs often work alone whereas hunting requires a more intense cooperation.

This study adds evidence to the evolutionary theory that dogs and humans chose each other, rather than the older theory that humans intentionally sought out wolf pups to raise on their own. Either way, there have been clear benefits for the dogs, Chambers said.

"Dogs are everywhere humans are," she said. "If we think that dogs are successful as a species if there are lots of them, then they have been able to thrive. They have hitched themselves to us and followed us all over the world. It's been a very successful relationship."

Credit: 
Washington State University

Oncotarget: Improved therapeutic efficacy of unmodified anti-tumor antibodies

image: Combination therapy TA99/ICB reduced the lung tumor burden in the B16 model of metastases. C57BL/6 mice were inoculated B16 cells via tail vein injection, and treatment with anti-CTLA4 (A) or anti-PD1 (B) alone or in combination with TA99 was administered as described in Figure 3A. After 21 days, lungs were harvested and fixed, and metastatic nodules counted. The combination of TA99 mAb with immune checkpoint blockade reduced the lung metastases burden. Mean ± SEM is shown. *p < 0.05.

Image: 
Correspondence to - Angela M. Christiano - amc65@cumc.columbia.edu

The cover for issue 2 of Oncotarget features Figure 4, "Combination therapy TA99/ICB reduced the lung tumor burden in the B16 model of metastases," published in "Improved therapeutic efficacy of unmodified anti-tumor antibodies by immune checkpoint blockade and kinase targeted therapy in mouse models of melanoma" by Pérez-Lorenzo, et al. which reported that here, the authors showed that removing immune suppression and enhancing stimulatory signals increased the anti-tumor activity of unmodified TA99 antibodies with a significant reduction of growth of solid tumors and lung metastases in mouse models of melanoma.

Immune checkpoint blockade enhanced the efficacy of TA99, which was associated with greater CD8 /Foxp3 , NK1.1 and dendritic cell infiltrates, suggestive of an increased anti-tumor innate and adaptive immune responses.

Moreover, they found an improved therapeutic effect when YUMM tumor-bearing mice were treated with TA99 combined with MEKi and immune checkpoint blockade.

The Oncotarget findings suggest that MEKi induced an increased expression of tumor-associated antigens, which in combination with anti-tumor antibodies, generated a robust adaptive anti-tumor response that was sustained by immune checkpoint inhibition therapy.

The Oncotarget findings suggest that MEKi induced an increased expression of tumor-associated antigens, which in combination with anti-tumor antibodies, generated a robust adaptive anti-tumor response that was sustained by immune checkpoint inhibition therapy.

The authors postulate that combining anti-tumor antibodies with standard-of-care strategies such as immune checkpoint blockade or targeted therapy, will improve therapeutic outcomes in cancer.

Dr. Angela M. Christiano from The Columbia University said, "It is well accepted that tumor development and progression is usually controlled by immunosurveillance mechanisms in which specific and non-specific immunological responses are constantly mounted against tumor cells."

Passive administration of anti-tumor antibodies generally functions by targeting malignant cells through IgG-mediated antibody-dependent cellular cytotoxicity, which is a rapid but relatively short-acting anti-tumor response.

Alternatively, they and others also demonstrated that the administration of anti-tumor antibodies induces long-lasting FcR-dependent tumor specific immunity in the host, with kinetics consistent with an induced adaptive immune response against the tumor.

In this model, anti-tumor antibodies, alone or in combination with chemotherapy, will promote innate cell-mediated ADCC, and the capture and processing of antigens by antigen presenting cells, with the subsequent stimulation and homing of antigen-specific effector T lymphocytes to the tumor site, leading to tumor elimination, a phenomenon the researchers and others referred to as the “vaccinal effect”.

With the use of the B16 and YUMM mouse models of melanoma and the anti-TYRP1 mouse monoclonal antibody TA99, we demonstrated that the therapeutic effects of these unmodified anti-tumor antibodies can be enhanced by ICB through the stimulation of both innate and adaptive anti-tumor immune responses.

In addition, they found that the MEK inhibitor -induced increased expression of melanosomal antigens further enhanced the anti-melanoma response to combination therapy with anti-tumor antibodies and immune checkpoint blockade in mouse models of melanoma.

The Christiano Research Team concluded in their Oncotarget Research Paper, "Together with our preclinical data, these results invite further clinical investigation of unmodified anti-tumor antibodies in combination with ICB and targeted therapies, and may represent promising and innovative therapeutic interventions for the successful management of patients with advanced melanoma and other cancers."

Sign up for free Altmetric alerts about this article

DOI - https://doi.org/10.18632/oncotarget.27868

Full text - https://www.oncotarget.com/article/27868/text/

Correspondence to - Angela M. Christiano - amc65@cumc.columbia.edu

Keywords -
anti-tumor antibodies,
targeted therapy,
immunotherapy,
combination therapies,
melanoma

About Oncotarget

Oncotarget is a biweekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology.

To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with:

SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/

Oncotarget is published by Impact Journals, LLC please visit http://www.ImpactJournals.com or connect with @ImpactJrnls

Journal

Oncotarget

DOI

10.18632/oncotarget.27868

Credit: 
Impact Journals LLC